Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Research, Inc.
707
mi
from 98109
West Jordan, UT
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Research, Inc.
707
mi
from 98109
West Jordan, UT
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Charlottesville Medical Research Inc.
2286
mi
from 98109
Charlottesville, VA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Charlottesville Medical Research Inc.
2286
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research Associates of Tidewater
2429
mi
from 98109
Norfolk, VA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research Associates of Tidewater
2429
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
National Clinical Research - Richmond, Inc.
2343
mi
from 98109
Richmond, VA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
National Clinical Research - Richmond, Inc.
2343
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Premier Clinical Research
228
mi
from 98109
Spokane, WA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Premier Clinical Research
228
mi
from 98109
Spokane, WA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
The Vancouver Clinic
139
mi
from 98109
Vancouver, WA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
The Vancouver Clinic
139
mi
from 98109
Vancouver, WA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
The Vancouver Clinic
139
mi
from 98109
Vancouver, WA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
The Vancouver Clinic
139
mi
from 98109
Vancouver, WA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Investigation Specialists
1702
mi
from 98109
Kenosha, WI
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Investigation Specialists
1702
mi
from 98109
Kenosha, WI
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Investigational Site Number 124902
2046
mi
from 98109
Brampton,
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Investigational Site Number 124902
2046
mi
from 98109
Brampton,
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Headache Wellness Center
2297
mi
from 98109
Greensboro, NC
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Headache Wellness Center
2297
mi
from 98109
Greensboro, NC
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Arkansas Clinical Research
1779
mi
from 98109
Little Rock, AR
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Arkansas Clinical Research
1779
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Sensible Healthcare
2538
mi
from 98109
Ocoee, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Sensible Healthcare
2538
mi
from 98109
Ocoee, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Territory Neurology & Research Institute
1212
mi
from 98109
Tucson, AZ
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Territory Neurology & Research Institute
1212
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
21st Century Neurology
1116
mi
from 98109
Phoenix, AZ
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
21st Century Neurology
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Arizona Research Center
1104
mi
from 98109
Phoenix, AZ
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Arizona Research Center
1104
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
962
mi
from 98109
Los Angeles, CA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Pacific Research Partners, LLC
678
mi
from 98109
Oakland, CA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Pacific Research Partners, LLC
678
mi
from 98109
Oakland, CA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Optimus Medical Group
934
mi
from 98109
San Francisco, CA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Optimus Medical Group
934
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Schuster Medical Research Institute
953
mi
from 98109
Sherman Oaks, CA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Schuster Medical Research Institute
953
mi
from 98109
Sherman Oaks, CA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
IMMUNOe International Research Centers
1032
mi
from 98109
Centennial, CO
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
IMMUNOe International Research Centers
1032
mi
from 98109
Centennial, CO
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research of South Florida
2728
mi
from 98109
Coral Gables, FL
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research of South Florida
2728
mi
from 98109
Coral Gables, FL
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Westside Center for Clinical Research
2452
mi
from 98109
Jacksonville, FL
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Westside Center for Clinical Research
2452
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solutions, Inc.
2457
mi
from 98109
Jacksonville, FL
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc.
2457
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Meridien Research
2527
mi
from 98109
Tampa, FL
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Meridien Research
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Atlanta Center for Medical Research
2178
mi
from 98109
Atlanta, GA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Atlanta Center for Medical Research
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Diamond Headache Clinic
1730
mi
from 98109
Chicago, IL
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Diamond Headache Clinic
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Josephson Wallack Munshower Neurology P.C
1870
mi
from 98109
Indianapolis, IN
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Josephson Wallack Munshower Neurology P.C
1870
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates, LLC
1440
mi
from 98109
Wichita, KA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates, LLC
1440
mi
from 98109
Wichita, KA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Novex Clinical Research, LLC
2513
mi
from 98109
New Bedford, MA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Novex Clinical Research, LLC
2513
mi
from 98109
New Bedford, MA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Healthcare Research Network - Hazelwood
1707
mi
from 98109
Hazelwood, MO
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Healthcare Research Network - Hazelwood
1707
mi
from 98109
Hazelwood, MO
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Nevada Headache Institute
878
mi
from 98109
Las Vegas, NV
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Nevada Headache Institute
878
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Bio Behavioral Health
2418
mi
from 98109
Toms River, NJ
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Bio Behavioral Health
2418
mi
from 98109
Toms River, NJ
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Regional Clinical Research
2261
mi
from 98109
Binghamton, NY
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Regional Clinical Research
2261
mi
from 98109
Binghamton, NY
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
SPRI Clinical Trials LLC
2407
mi
from 98109
Brooklyn, NY
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
SPRI Clinical Trials LLC
2407
mi
from 98109
Brooklyn, NY
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
High Point Clinical Trials Center
2291
mi
from 98109
High Point, NC
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
High Point Clinical Trials Center
2291
mi
from 98109
High Point, NC
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Neurology and Neuroscience Associates
2039
mi
from 98109
Akron, OH
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Neurology and Neuroscience Associates
2039
mi
from 98109
Akron, OH
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati College of Medicine
1963
mi
from 98109
Cincinnati, OH
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati College of Medicine
1963
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Urgent Care Specialists, LLC
2004
mi
from 98109
Columbus, OH
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Urgent Care Specialists, LLC
2004
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Urgent Care Specialists, LLC
1965
mi
from 98109
Dayton, OH
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Urgent Care Specialists, LLC
1965
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
IPS Research Company
1522
mi
from 98109
Oklahoma City, OK
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
IPS Research Company
1522
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Oregon Neurology Associates
250
mi
from 98109
Springfield, OR
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Oregon Neurology Associates
250
mi
from 98109
Springfield, OR
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research of Philadelphia LLC
2377
mi
from 98109
Philadelphia, PA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research of Philadelphia LLC
2377
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Mountain View Clinical Research
2229
mi
from 98109
Greer, SC
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Mountain View Clinical Research
2229
mi
from 98109
Greer, SC
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Coastal Carolina Research Center
2425
mi
from 98109
Mount Pleasant, SC
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Coastal Carolina Research Center
2425
mi
from 98109
Mount Pleasant, SC
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials
1678
mi
from 98109
Dallas, TX
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials
1678
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Network
1888
mi
from 98109
Houston, TX
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Network
1888
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Clinpoint Trial, LLC
1698
mi
from 98109
Waxahachie, TX
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Clinpoint Trial, LLC
1698
mi
from 98109
Waxahachie, TX
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Foothill Family Clinic
701
mi
from 98109
Salt Lake City, UT
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Foothill Family Clinic
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Health Research of Hampton Roads
2412
mi
from 98109
Newport News, VA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Health Research of Hampton Roads
2412
mi
from 98109
Newport News, VA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Sentara Neurology Specialists
2444
mi
from 98109
Virginia Beach, VA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Sentara Neurology Specialists
2444
mi
from 98109
Virginia Beach, VA
Click here to add this to my saved trials